Physician profile
Akeem Bartley
NPI 1336728716
$5,361.24
in general payments reported to CMS, 2019-2025
13 companies · $2,180 in 2025
The $2,180 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $419 · 2022: $567 · 2023: $1,136 · 2024: $1,059 · 2025: $2,180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,863 · Travel and Lodging: $1,217 · Education: $296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,863.45 |
| Travel and Lodging | $1,216.78 |
| Education | $295.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,886.17 | 2021-2025 | Endurant Iis, Heli-Fx Endoanchor System |
| Bolton Medical INC | $1,155.99 | 2025 | Treo Abdominal Stent-Graft System |
| Shockwave Medical, INC | $612.43 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Terumo Medical Corporation | $368.54 | 2022-2025 | Azur Cx Detachable |
| Boston Scientific Corporation | $335.88 | 2023-2025 | Accolade Sr |
| Cardiovascular Systems INC. | $214.75 | 2023 | Diamondback Peripheral |
| Stryker Corporation | $203.37 | 2025 | Artix Mt |
| Silk Road Medical, INC. | $177.92 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Abbott Laboratories | $133.87 | 2025 | Esprit |
| Penumbra, INC. | $120.67 | 2025 | Ruby Coil |
| Philips North America LLC | $61.18 | 2024 | (Dd3) Venous Stent Und |
| Mimedx Group, INC. | $45.53 | 2024-2025 | |
| Kci USA, INC. | $44.94 | 2022-2023 | V.A.C. Veraflo, Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akeem Bartley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.